相关实验视频

Updated: Jan 7, 2026

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

高效衍生hiPSC衍生的光受体前体细胞及其神经保护作用在视网膜退化中的有效衍生

Yuxin Du¹, Jingjing Cao², Lumeng Niu³

¹Eye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

|December 30, 2025

概括

人类干细胞衍生的光受体前体细胞 (PPCs) 显示出治疗视网膜炎色素炎 (RP) 的前途. 通过AM580的化学处理,可以获得高纯度的PPC,在RP模型中证明了视网膜保护作用和结构整合.

科学领域:

眼科医生眼科眼科
再生医学是一种再生医学.
干细胞生物学干细胞生物学

背景情况:

视网膜退行性疾病如视网膜色素炎 (RP) 目前缺乏有效的视力恢复疗法.
光受体前体细胞 (PPC) 移植为视力丧失提供了一个有希望的再生策略.
人类诱导的多能干细胞 (hiPSCs) 为产生治疗细胞提供了一种可再生的来源.

研究的目的:

使用AM580.0有效地将hiPSC分化为高度纯的光受体前体细胞 (PPCs).
在视网膜色素炎的临床前模型中评估hiPSC衍生的PPCs的治疗潜力.
评估在退化的视网膜内移植的PPCs的结构整合和功能能力.

主要方法:

使用视网膜类类似物AM580将hiPSC分化为PPC,达到高纯度 (>99.9%).
一种N-甲基-N-氨酸尿素 (NMU) 诱导的视网膜色素炎大鼠模型被用于测试PPC移植.
移植的PPC被分析为生存,分化 (杆/标记物) 和突触集成 (CtBP2表达).

主要成果:

在AM580治疗中,从hiPSC中获得了高度纯净的CRX+/LHX4+ PPC.
移植的hiPSC衍生的PPC表现出视网膜保护作用,这在RP模型中得到了视网膜结构的改善.
捐赠者PPCs表达了光受体标记物,并在宿主双极细胞附近形成了CtBP2+前突触专业化,表明了功能整合.

结论:

使用AM580生成的hiPSC衍生的PPCs是可行的视网膜再生细胞来源.
这些PPC在RP模型中显示出显著的视网膜保护作用和结构整合能力.
对hiPSC衍生PPC移植的进一步研究有可能用于治疗视力威胁的视网膜退化.

关键词:

细胞生物学细胞生物学分子生物学分子生物学神经科学神经科学

更多相关视频

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...